{
 "drug": "Glyburide Tablet",
 "asOf": "2026-08-25",
 "status": "discontinuing",
 "since": "08/10/2026",
 "dayN": 15,
 "cat": "Endocrinology/Metabolism",
 "companies": [
  "Sanofi-Aventis U.S. LLC"
 ],
 "reasons": [],
 "records": [
  {
   "discontinued_date": "08/10/2026",
   "update_type": "New",
   "initial_posting_date": "08/10/2026",
   "package_ndc": "0093-9364-01",
   "generic_name": "Glyburide Tablet",
   "contact_info": "800-633-1610",
   "related_info": "A business decision was made to discontinue manufacture of the drug.",
   "openfda": {
    "application_number": [
     "NDA017532"
    ],
    "brand_name": [
     "GLYBURIDE"
    ],
    "generic_name": [
     "GLYBURIDE"
    ],
    "manufacturer_name": [
     "TEVA Pharmaceuticals USA Inc"
    ],
    "product_ndc": [
     "0093-9364",
     "0093-9477",
     "0093-9433"
    ],
    "product_type": [
     "HUMAN PRESCRIPTION DRUG"
    ],
    "route": [
     "ORAL"
    ],
    "substance_name": [
     "GLYBURIDE"
    ],
    "rxcui": [
     "197737",
     "310534",
     "310537"
    ],
    "spl_id": [
     "84b83205-8813-494e-933e-a70697393744"
    ],
    "spl_set_id": [
     "50d16f1d-c814-4411-8749-62561321ecce"
    ],
    "package_ndc": [
     "0093-9477-53",
     "0093-9433-01",
     "0093-9433-05",
     "0093-9364-01",
     "0093-9364-05",
     "0093-9364-10"
    ],
    "nui": [
     "N0000175608",
     "M0020795"
    ],
    "pharm_class_epc": [
     "Sulfonylurea [EPC]"
    ],
    "pharm_class_cs": [
     "Sulfonylurea Compounds [CS]"
    ],
    "unii": [
     "SX6K58TVWC"
    ]
   },
   "update_date": "08/10/2026",
   "therapeutic_category": [
    "Endocrinology/Metabolism"
   ],
   "dosage_form": "Tablet",
   "presentation": "Diabeta, Tablet, 5 mg (NDC 0093-9364-01)",
   "company_name": "Sanofi-Aventis U.S. LLC",
   "status": "To Be Discontinued"
  },
  {
   "discontinued_date": "08/10/2026",
   "update_type": "New",
   "initial_posting_date": "08/10/2026",
   "package_ndc": "0093-9477-53",
   "generic_name": "Glyburide Tablet",
   "contact_info": "800-633-1610",
   "related_info": "A business decision was made to discontinue manufacture of the drug.",
   "openfda": {
    "application_number": [
     "NDA017532"
    ],
    "brand_name": [
     "GLYBURIDE"
    ],
    "generic_name": [
     "GLYBURIDE"
    ],
    "manufacturer_name": [
     "TEVA Pharmaceuticals USA Inc"
    ],
    "product_ndc": [
     "0093-9477",
     "0093-9433",
     "0093-9364"
    ],
    "product_type": [
     "HUMAN PRESCRIPTION DRUG"
    ],
    "route": [
     "ORAL"
    ],
    "substance_name": [
     "GLYBURIDE"
    ],
    "rxcui": [
     "197737",
     "310534",
     "310537"
    ],
    "spl_id": [
     "84b83205-8813-494e-933e-a70697393744"
    ],
    "spl_set_id": [
     "50d16f1d-c814-4411-8749-62561321ecce"
    ],
    "package_ndc": [
     "0093-9477-53",
     "0093-9433-01",
     "0093-9433-05",
     "0093-9364-01",
     "0093-9364-05",
     "0093-9364-10"
    ],
    "nui": [
     "N0000175608",
     "M0020795"
    ],
    "pharm_class_epc": [
     "Sulfonylurea [EPC]"
    ],
    "pharm_class_cs": [
     "Sulfonylurea Compounds [CS]"
    ],
    "unii": [
     "SX6K58TVWC"
    ]
   },
   "update_date": "08/10/2026",
   "therapeutic_category": [
    "Endocrinology/Metabolism"
   ],
   "dosage_form": "Tablet",
   "presentation": "Diabeta, Tablet, 1.25 mg (NDC 0093-9477-53)",
   "company_name": "Sanofi-Aventis U.S. LLC",
   "status": "To Be Discontinued"
  },
  {
   "discontinued_date": "08/10/2026",
   "update_type": "New",
   "initial_posting_date": "08/10/2026",
   "package_ndc": "0093-9433-01",
   "generic_name": "Glyburide Tablet",
   "contact_info": "800-633-1610",
   "related_info": "A business decision was made to discontinue manufacture of the drug.",
   "openfda": {
    "application_number": [
     "NDA017532"
    ],
    "brand_name": [
     "GLYBURIDE"
    ],
    "generic_name": [
     "GLYBURIDE"
    ],
    "manufacturer_name": [
     "TEVA Pharmaceuticals USA Inc"
    ],
    "product_ndc": [
     "0093-9433",
     "0093-9477",
     "0093-9364"
    ],
    "product_type": [
     "HUMAN PRESCRIPTION DRUG"
    ],
    "route": [
     "ORAL"
    ],
    "substance_name": [
     "GLYBURIDE"
    ],
    "rxcui": [
     "197737",
     "310534",
     "310537"
    ],
    "spl_id": [
     "84b83205-8813-494e-933e-a70697393744"
    ],
    "spl_set_id": [
     "50d16f1d-c814-4411-8749-62561321ecce"
    ],
    "package_ndc": [
     "0093-9477-53",
     "0093-9433-01",
     "0093-9433-05",
     "0093-9364-01",
     "0093-9364-05",
     "0093-9364-10"
    ],
    "nui": [
     "N0000175608",
     "M0020795"
    ],
    "pharm_class_epc": [
     "Sulfonylurea [EPC]"
    ],
    "pharm_class_cs": [
     "Sulfonylurea Compounds [CS]"
    ],
    "unii": [
     "SX6K58TVWC"
    ]
   },
   "update_date": "08/10/2026",
   "therapeutic_category": [
    "Endocrinology/Metabolism"
   ],
   "dosage_form": "Tablet",
   "presentation": "Diabeta, Tablet, 2.5 mg (NDC 0093-9433-01)",
   "company_name": "Sanofi-Aventis U.S. LLC",
   "status": "To Be Discontinued"
  },
  {
   "discontinued_date": "08/10/2026",
   "update_type": "New",
   "initial_posting_date": "08/10/2026",
   "package_ndc": "0093-9364-10",
   "generic_name": "Glyburide Tablet",
   "contact_info": "800-633-1610",
   "related_info": "A business decision was made to discontinue manufacture of the drug.",
   "openfda": {
    "application_number": [
     "NDA017532"
    ],
    "brand_name": [
     "GLYBURIDE"
    ],
    "generic_name": [
     "GLYBURIDE"
    ],
    "manufacturer_name": [
     "TEVA Pharmaceuticals USA Inc"
    ],
    "product_ndc": [
     "0093-9364",
     "0093-9477",
     "0093-9433"
    ],
    "product_type": [
     "HUMAN PRESCRIPTION DRUG"
    ],
    "route": [
     "ORAL"
    ],
    "substance_name": [
     "GLYBURIDE"
    ],
    "rxcui": [
     "197737",
     "310534",
     "310537"
    ],
    "spl_id": [
     "84b83205-8813-494e-933e-a70697393744"
    ],
    "spl_set_id": [
     "50d16f1d-c814-4411-8749-62561321ecce"
    ],
    "package_ndc": [
     "0093-9477-53",
     "0093-9433-01",
     "0093-9433-05",
     "0093-9364-01",
     "0093-9364-05",
     "0093-9364-10"
    ],
    "nui": [
     "N0000175608",
     "M0020795"
    ],
    "pharm_class_epc": [
     "Sulfonylurea [EPC]"
    ],
    "pharm_class_cs": [
     "Sulfonylurea Compounds [CS]"
    ],
    "unii": [
     "SX6K58TVWC"
    ]
   },
   "update_date": "08/10/2026",
   "therapeutic_category": [
    "Endocrinology/Metabolism"
   ],
   "dosage_form": "Tablet",
   "presentation": "Diabeta, Tablet, 5 mg (NDC 0093-9364-10)",
   "company_name": "Sanofi-Aventis U.S. LLC",
   "status": "To Be Discontinued"
  }
 ]
}